USPTO serial 79461393
MYCIT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- —
What this means
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
Need help with MYCIT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for the treatment of cancer, in particular based on nucleic acids and/or proteins; personalised patient-specific medicinal products, in particular based on nucleic acids and/or proteins. | ACTIVE | — |
| 009 | Scientific apparatuses and instruments; software algorithms as software programs, in particular for the detection and collection of mutations in cancer patients. | ACTIVE | — |
| 010 | High-throughput analytical instruments, in particular instruments for next-generation sequencing [NGS] for medical issues, as well as for gene expression profiling and for the detection of epigenetic changes. | ACTIVE | — |
| 042 | Research and development in the field of cancer immunotherapy, in particular research and development in the field of human and veterinary medical diagnostics and treatment by means of molecular-biological, genetic, biotechnological and/or bioinformatic methods, in particular by means of next-generation sequencing; diagnostics of tumour markers für personalised treatment as scientific laboratory services or as part of scientific research for medical purposes. | ACTIVE | — |
| 044 | Medical, veterinary-medical and pharmaceutical advisory services, in particular in the selection of suitable treatments for cancer diseases of all kinds; performance of analyses and treatments as part of personalised cancer immunotherapy; provision of treatments based on nucleic acids and/or checkpoint inhibitors. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 23, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 22, 2026 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |